Efficient derivation of microglia-like cells from human pluripotent stem cells.
- Authors
- Muffat, Julien; Li, Yun; Yuan, Bingbing; Mitalipova, Maisam; Omer, Attya; Corcoran, Sean; Bakiasi, Grisilda; Tsai, Li-Huei; Aubourg, Patrick; Ransohoff, Richard M; Jaenisch, Rudolf
- Year
- 2016
- Journal
- Nature medicine
- PMID
- 27668937
- DOI
- 10.1038/nm.4189
- PMCID
- PMC5101156
Microglia, the only lifelong resident immune cells of the central nervous system (CNS), are highly specialized macrophages that have been recognized to have a crucial role in neurodegenerative diseases such as Alzheimer's, Parkinson's and adrenoleukodystrophy (ALD). However, in contrast to other cell types of the human CNS, bona fide microglia have not yet been derived from cultured human pluripotent stem cells. Here we establish a robust and efficient protocol for the rapid production of microglia-like cells from human (h) embryonic stem (ES) and induced pluripotent stem (iPS) cells that uses defined serum-free culture conditions. These in vitro pluripotent stem cell-derived microglia-like cells (termed pMGLs) faithfully recapitulate the expected ontogeny and characteristics of their in vivo counterparts, and they resemble primary fetal human and mouse microglia. We generated these cells from multiple disease-specific cell lines and find that pMGLs derived from an hES model of Rett syndrome are smaller than their isogenic controls. We further describe a platform to study the integration and live behavior of pMGLs in organotypic 3D cultures. This modular differentiation system allows for the study of microglia in highly defined conditions as they mature in response to developmentally relevant cues, and it provides a framework in which to study the long-term interactions of microglia residing in a tissue-like environment.
induction of primitive myelogenesis from human pluripotent stem cells(a) top panel: example image depicting the typical formation of cystic EBs bound by a single cell layer. lower panel: example of neuralized spheroid EB structures. Scale bars: 200ΞΌm. (b) typical appearance of endothelial lawns emerging from plated cystic EBs (on PDL coated plastic). Phase panels display the island formations with raised edges (left), and the progressive merger of such edges into raised ropes. Subsequent panels depict staining for VE-Cadherin (green), and c-kit (magenta). Scale Bars: 80ΞΌm. (c) higher magnification of raised structures surrounding islands (phase), staining for CD41 (green), and CD235a (magenta). Scale bar: 25ΞΌm. (d) after 2 weeks in suspension culture, cystic EBs can be plated to PDL coated plastic (left, phase contrast. Scale bar: 200ΞΌm), and large domains stain positive for the nucleus-localized transcription factor PU.1 (right, green). (e) Delamination of grape-like structures towards the luminal side from YS-EBs (red arrowheads, top left and right, scale bars:40 ΞΌm and 25ΞΌm, respectively). Putative myeloid cells are seen delaminating outward into the suspension medium (red arrowhead, bottom left, scale bar: 25ΞΌm). Homogeneous population of round motile cells seen delaminating and spreading away from the source YS-EB (Bottom right, scale bar: 80ΞΌm).
characterization of phagocytes delaminating from cystic YS-EBs(a) differentiation protocol schematic showing the suspension culture (top row), and the selective adherent conditions (bottom row). (b) low magnification view of delaminated lawn after plating stained for nuclear DAPI (grey scale), nuclear PU.1 (magenta) and membrane CD11b/ITGAM (green pseudocolor). Merged PU.1 and CD11b channels are depicted in the right panel. Scale bar: 25ΞΌm. (c) high magnification view of ramified cell in resting culture viewed under phase contrast (grey scale) and stained for nuclear PU.1 (magenta) and cytoplasmic IBA1/AIF1. Merged PU.1 and IBA1 channels are depicted in the right panel. Scale bar: 5ΞΌm (d, e) FACS scatter plots of harvested pMGLs for CD11b and IBA1 (left) or CD45 (right). (f) left panel, example image depicting the migratory path (white dashed arrow) of a single pMGL on a fluorescent bead lawn (yellow), as well as intracellular accumulation of phagocytosed fluorescent beads (arrow head) Scale bar: 10ΞΌm. Right panel, example image depicting a cotton fiber opsonized by pMGLs (scale bar: 25ΞΌm). (g) extracted frames from supplementary movie 2 depicting fluorescent beads (red arrowheads) taken up by a single pMGL Scale bar: 3ΞΌm. h: Quantification of pMGL EdU incorporation, measured at 2 weeks and 2 months (mean Β± s.e.m. of 2 biological replicates, t-test, P<0.05).
pMGLs adopt ramified morphologies over time and express specific markers of microglia(a) example phase contrast images of depicting morphologies of human fetal microglia (hFMG; left) and pMGLs derived from human ES cells (hES pMGLs, middle) or induced pluripotent stem cells (iPS pMGLs, right). Scale bars: 25ΞΌm. (b) example high magnification images depicting morphologies of mouse primary neonatal microglia (mNMG, left), hFMG (middle) and hiPS pMGLs (right). scale bars: 10ΞΌm. (c) Example of phenotypic output in freshly plated MECP2 mutant (right panel) and isogenic wild-type cells (left panel, scale bar: 25ΞΌm). Average cell spread (surface) and perimeter are significantly lower in MECP2 mutant microglia (mean Β± s.e.m. for 2 biological replicates, TTEST, p<0.05). (eβf) example images of ramified pMGLs (phase) stained for DAPI (magenta) and either TMEM119 (e, green) or P2RY12 (f, green). Scale bars: 10ΞΌm (g) Example confocal image representing an optical slice of wider field-of-view, stained for IBA1 (red), TMEM119 (green) and CD45 (white). Scale bar: 20ΞΌm.
pMGLs cytokine profiles in response to endotoxin challenge(a) Baseline cytokine profiler assay from 105 pMGLs conditioning 2mL of NGD in 24 hours. Top panel: 10β² exposure, showing baseline secretion of detectable CCL2, MIP1Ξ±/Ξ², CXCL1 and IL8. Lower Panel: profile after stimulation for 24hours with 100ng/mL LPS and 20ng/mL IFN-Ξ³. IL6, TNFΞ±, MIP1Ξ±/Ξ² and CXCL10 display a dramatic increase. (b) map, to scale, of the spots blotted in panel a. Green highlights cytokines showing a significant upregulation. (c, d) Quantitative qPCR of TNFΞ± (c) and IL6 (d) transcription in pMGLs at baseline (β) and after LPS stimulation (+). Data are presented as mean Β± s.e.m. from 2 biological replicates, t-test significance is reported.
pMGLs recapitulate the consensus signature distinguishing primary microglia from other macrophages(a) Quantification of normalized expression (counts from RNAseq data) of the indicated genes for pMGLs (black bars, N=5), primary human fetal microglia (red bars, hFMG, N=2), and differentiated human neural progenitors (red bars, Diff. NPCs, N=4). Data are presented as mean Β± s.e.m. (b) Dendrogram depicting the results of unbiased hierarchical clustering of fMGs (N=2), pMGLs (N=5) and NPCs (N=4) derived in this study, compared to a published dataset (GSE73721) 31 for adult primary microglia (N=3), fetal astrocytes (N=6), mature astrocytes (N=12), neurons (N=1) and whole cortex (N=4), using genes in Suppl. Table 8.
neural co-cultures enhance the microglial signature of pMGLs(a) top: schematic representation of transwell culture system exposing pMGLs to conditioned medium from differentiating neuro-glial cultures. Bottom: schematic representation of direct re-aggregation after GFP transduction, as free-floating spheroids or 3D stacks in transwells. (b) Principal component analysis comparing RNAseq profiles from differentiated neural cultures (full squares, NPC1 in red, NPC2 in blue, NPC3 in green) to those of primary fetal microglia (fMG1 and fMG2, open triangles. fMG1+ NCM, closed triangle), and pMGLs (circles, pMGL1 in red, pMGL2 in blue, and pMGL3 in green) in the absence (open circles) or presence (full circles) of neural progenitor conditioned medium (+NCM). N=1 for each sequencing data point. (c) phase contrast (left) and fluorescence (right) images depicting the relative tiling position of GFP-labeled pMGLs in 3d culture on transwell. Scale bar: 200 ΞΌm. (d) representative image of a GFP-positive pMGL (grey scale) after 4 weeks in 3D neural stacks (live observation). Scale bar: 10ΞΌm. (e): Optical section through a fixed 3D neuroglial culture (without embedded pMGLs), stained for DAPI (blue, top), neuronal MAP2 (green, middle) and astrocytic GFAP (magenta, bottom). Scale bar: 50ΞΌm. (f) Maximum projection of supplementary movie 5 (scale bar: 2ΞΌm) pointing to rapidly extending (yellow arrowhead) and retracting (red arrowhead) protrusions in the 3D neuroglial cultures. (g) 1/5 frames of supplementary movies S5 and S6, showing branch movements over 300s. (h) Example montage of time-lapse images depicting GFP-labeled pMGLs (grayscale) response to localized cellular damage in 3D culture. Yellow arrowhead indicates the site of two-photon laser ablation after 5 minutes of acquisition. Red arrowheads point to microglia-like cells further away from injury, not reacting to the damage. Bottom right panel represent the color-coded individual trajectories of pMGLs during acquisition, highlighting radial migration towards the injury. Scale bar = 100ΞΌm.
| Name | Type |
|---|---|
| 2D cultures local | drug |
| 3D cultures | drug |
| 3D neuroglial culture local | cohort |
| 5% O2 local | drug |
| accutase | drug |
| ADORA3 local | gene |
| ADP | drug |
| Adrenoleukodystrophy local | phenotype |
| adult human microglia local | anatomy |
| adult human microglia local | phenotype |
| Adult human microglia local | phenotype |
| adult microglia local | anatomy |
| adult primary microglia local | cohort |
| AF647 conjugated secondary local | drug |
| AIF1 | gene |
| Alexa 568 local | drug |
| Alexa 647 local | drug |
| Alexa Fluor 488 | drug |
| Alexa Fluor 594 | drug |
| Alzheimer's disease | phenotype |
| amoeboid morphology local | phenotype |
| animals | cohort |
| apoE | gene |
| astrocytes | phenotype |
| ATP | drug |
| autism | phenotype |
| bFGF | drug |
| BIN1 | gene |
| Biotin local | drug |
| blood-brain barrier | anatomy |
| bone marrow-derived macrophages local | phenotype |
| brain cells local | phenotype |
| branching patterns local | phenotype |
| BSA | drug |
| C1qa | gene |
| C57BL/6J | cohort |
| CCL2 local | drug |
| CD11b | gene |
| CD235a local | gene |
| CD33 | gene |
| CD41 | gene |
| CD45 | gene |
| CD5L local | gene |
| CDH5 local | gene |
| cell-autonomous phenotypes local | phenotype |
| cell lines local | phenotype |
| cell proliferation | phenotype |
| central nervous system | anatomy |
| CFP local | gene |
| chemokines local | drug |
| c-kit | gene |
| CNS | anatomy |
| Collagenase IV local | drug |
| collagenase type IV local | drug |
| conditioned medium from differentiating neural cultures local | drug |
| control | cohort |
| control subjects | cohort |
| cortex | anatomy |
| cortical cups local | anatomy |
| cotton fiber local | drug |
| CRIP1 local | gene |
| CSF1 local | drug |
| CSF1 | gene |
| CSF1 mutant mice local | cohort |
| CSF1R | gene |
| CSF1R agonist local | drug |
| CSF1R mutant animals local | cohort |
| Cst3 | gene |
| CXCL1 local | drug |
| CXCL10 local | drug |
| cystic embryoid bodies local | phenotype |
| cytokines | drug |
| DAPI | drug |
| depression | phenotype |
| DESeq local | drug |
| differentiated human neural progenitors local | cohort |
| differentiated neural progenitors local | cohort |
| differentiated NPCs local | phenotype |
| Diff. NPCs local | cohort |
| disease subjects local | cohort |
| DMEM/F12 | drug |
| DNase I | drug |
| donkey serum | drug |
| dorsomorphin | drug |
| early haemogenic endothelia local | phenotype |
| ECL reagent local | drug |
| ECM | drug |
| EdU local | drug |
| endothelial-like cell lawns local | phenotype |
| ENTPD1 local | gene |
| ES-wibr1 local | cohort |
| excitotoxicity | phenotype |
| extracellular matrix | drug |
| Extracellular sodium local | drug |
| FastQC local | drug |
| fastq_screen local | drug |
| FcR blocking reagent local | drug |
| FeatureCounts local | drug |
| fetal astrocytes local | anatomy |
| fetal astrocytes local | cohort |
| fetal bovine serum | drug |
| fetal microglia local | anatomy |
| FGF | drug |
| FGF2 | drug |
| fibers | drug |
| First trimester aborted fetuses local | cohort |
| fluorescent beads local | drug |
| fluorescent latex beads local | drug |
| fMG local | cohort |
| FMG local | cohort |
| fMG1 local | cohort |
| fMG2 local | cohort |
| fMGs local | anatomy |
| fMGs local | cohort |
| FMGs local | phenotype |
| FU-GFP-IRES-PURO-W lentivirus construct local | drug |
| Galactose local | drug |
| GAPDH | gene |
| geneontology.org local | drug |
| GEO datasets local | cohort |
| GFAP | gene |
| GFP | drug |
| glass coverslips local | drug |
| glia | phenotype |
| glucose | drug |
| glutamate | drug |
| Glutamax | drug |
| glutamine | drug |
| Glutamine/Glutamax local | drug |
| GM2 ganglioside local | drug |
| GPR34 local | gene |
| GPR56 local | gene |
| GSE55536 local | cohort |
| GSE73721 local | cohort |
| GYPA local | gene |
| HBSS | drug |
| hES cells local | cohort |
| hES-WIBR3 local | cohort |
| HEXB local | gene |
| hFMG local | cohort |
| hiPS cells local | cohort |
| HMDM local | cohort |
| HMDM local | phenotype |
| Human cerebrospinal fluid local | drug |
| human donors local | cohort |
| human fetal microglia local | cohort |
| human pluripotent stem cell-derived mature neural cells local | cohort |
| Iba1 | gene |
| IFN-Ξ³ | drug |
| IL-34 local | drug |
| IL34 local | gene |
| IL-6 | drug |
| IL6 | gene |
| IL-8 local | drug |
| IL8 local | drug |
| Illumina | drug |
| immature microglia local | cohort |
| inert plastic beads local | drug |
| inflammation | phenotype |
| insulin | drug |
| iPS-ALD1 local | cohort |
| iPS-ALD1/2/3/4 local | cohort |
| iPS-ALD4 local | cohort |
| iPS-AMN1/2/3 local | cohort |
| iPS cells | cohort |
| iPS-derived neural cells local | anatomy |
| iPSDM local | cohort |
| iPSDM local | phenotype |
| iPS-fAD1/3 local | cohort |
| iPS-fAD2 local | cohort |
| iPS-wt1 local | cohort |
| iPS-wt1/2/3 local | cohort |
| iPS-wt4 local | cohort |
| iPS-wt4/5 local | cohort |
| iPS-wt5 local | cohort |
| IRF8 local | gene |
| Iron-loaded transferrin local | drug |
| Iron salts local | drug |
| ITGA2B | gene |
| ITGAM | gene |
| ITGB2 | gene |
| KAPA Illumina Library Quantification Kit local | drug |
| KIT | gene |
| knockout serum replacement | drug |
| Lactic acid local | drug |
| LAIR1 local | gene |
| laminin | drug |
| lentivirus | drug |
| LGMN local | gene |
| Lipid-loaded albumin (Albumax) local | drug |
| Lower cell spread local | phenotype |
| LPS | drug |
| MAP2 | gene |
| matrigel | drug |
| mature astrocytes local | anatomy |
| mature astrocytes local | cohort |
| mature microglia local | anatomy |
| MeCP2 | gene |
| MECP2 mutant microglia local | phenotype |
| MERTK local | gene |
| methanol | drug |
| MGdM local | drug |
| MGdM medium local | drug |
| MGM local | drug |
| microglia local | cohort |
| microglia | phenotype |
| MIP1a local | drug |
| MIP1Ξ± local | drug |
| MIP1Ξ² local | drug |
| mNMG local | cohort |
| modified polystyrene (Primaria) plates local | drug |
| monocyte-derived macrophages local | phenotype |
| mouse anti-CD45-AF647 local | drug |
| mouse brain | anatomy |
| mouse embryonic fibroblasts (MEFs) local | cohort |
| mouse neonatal microglia local | cohort |
| MYB | gene |
| myeloid cells | phenotype |
| NanoDrop ND-1000 spectrophotometer local | drug |
| Nanog | gene |
| NCM local | drug |
| neonates | cohort |
| neural cultures local | phenotype |
| neuralized spheroids local | phenotype |
| neural progenitors | phenotype |
| Neural tube local | anatomy |
| Neurobasal | drug |
| Neuro-Glial Differentiation media local | drug |
| neurons | phenotype |
| NGD local | drug |
| NGD base local | drug |
| NGD medium local | drug |
| NGM medium local | drug |
| non-essential amino acids | drug |
| NPC1 local | cohort |
| NPC2 local | cohort |
| NPC3 local | cohort |
| NPCs | cohort |
| OLFML3 local | gene |
| oligodendrocytes | phenotype |
| organotypic neural cultures local | drug |
| OSKM local | drug |
| OSKML local | drug |
| other brain cells local | anatomy |
| p24 ELISA local | drug |
| P2RY12 | gene |
| P2RY13 local | gene |
| P2Y12 local | gene |
| P2Y13 local | gene |
| panther algorithm local | drug |
| paraformaldehyde | drug |
| Parkinson's disease | phenotype |
| peripheral macrophages local | cohort |
| PET transwell local | drug |
| phagocytosis | phenotype |
| phenol red local | drug |
| pluripotent stem cells local | phenotype |
| pMGL local | cohort |
| pMGLs local | anatomy |
| pMGLs local | cohort |
| pMGLs local | drug |
| pMGLs local | phenotype |
| poly-D-lysine | drug |
| Polyethyleneimine local | drug |
| polyethylenimine | drug |
| Polystyrene red-orange fluospheres local | drug |
| POU5F1 | gene |
| PRG4 local | gene |
| Primaria local | drug |
| Primaria plastic local | drug |
| Primary fetal human microglia local | phenotype |
| primary fetal microglia local | cohort |
| primary fetal microglia local | phenotype |
| primary human brain cells local | anatomy |
| primary human fetal microglia local | cohort |
| primary microglia | anatomy |
| primary microglia local | cohort |
| primary microglia local | phenotype |
| primary neurons local | anatomy |
| PROS1 | gene |
| PSC lines local | cohort |
| PTPRC | gene |
| pyruvate | drug |
| Qubit | drug |
| rabbit anti-IBA1 local | drug |
| ramified morphology local | phenotype |
| Ramified morphology local | phenotype |
| rat anti-CD11B-FITC local | drug |
| retinoic acid | drug |
| Rett microglia local | phenotype |
| Rett syndrome | phenotype |
| RNeasy Micro kit local | drug |
| Roche LightCycler 480 local | drug |
| ROCK | gene |
| rosette-forming neuroepithelium local | phenotype |
| rounded phenotype local | phenotype |
| SAA1 local | gene |
| SAA2 local | gene |
| samples | cohort |
| Sandhoff disease local | phenotype |
| schizophrenia | phenotype |
| ScienCell local | drug |
| SELPLG local | gene |
| Sendai virus | drug |
| serum | drug |
| SLPI local | gene |
| smaller microglia local | phenotype |
| SMART-Seq v4 Ultra Low Input RNA Kit local | drug |
| SPI1 | gene |
| STEMCCA lentivirus local | drug |
| Superscript III reverse transcriptase | drug |
| surveying behavior local | phenotype |
| SYBR Green PCR mix local | drug |
| TGFΞ² | drug |
| TgfΞ²1 | gene |
| TGFΞ²R1 local | gene |
| tissue-resident macrophages local | phenotype |
| TMEM119 local | gene |
| TNFΞ± | drug |
| TopHat v2.0.13 local | drug |
| trauma | phenotype |
| TREM2 | gene |
| Triton X-100 | drug |
| TXNIP | gene |
| undifferentiated neural progenitor conditioned medium local | drug |
| VE-Cadherin local | gene |
| VSVg | drug |
| Whitehead Institute local | cohort |
| whole cortex local | anatomy |
| WIBR1/2/3 local | cohort |
| X-tremeGENE 9 local | drug |
| Y27632 local | drug |
| Yolk sac local | anatomy |
| Yolk Sac-EBs local | phenotype |
| Ξ²-mercaptoethanol | drug |
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Alzheimer's disease risk protein SorLA regulates ER homeostasis and lipid metabolism in human microglia, with conserved effects in neurons. | Haq I et al. | β | 2026 | β |
| Comparative lipidomics of iPSC-derived microglia protocols reveal lipid droplet and immune differences mediated by media composition. | Toda Robert A et al. | β | 2026 | β |
| Dissecting microglial contributions to neurodegenerative disease pathophysiology using human pluripotent stem cells. | Kim D et al. | β | 2026 | β |
| Engineering a Perfusion Bioreactor System for hiPSC-Derived Progenitor Co-Culture Capturing Microglial Features in CNS Development. | Gomes CM et al. | β | 2026 | β |
| Exploring retinal microglia: development, degeneration, and iPSC-derived model systems. | Gao ML et al. | β | 2026 | β |
| Functional genomic profiling of schizophrenia-associated genes reveals key microglial regulators. | Horng JE et al. | β | 2026 | β |
| Generation and characterization of iPSC-derived microglia for in vitro modeling of stimuli-specific neuroimmune responses. | Haskell AK et al. | β | 2026 | β |
| Immuno-Regulation of Brain Region-Specific Organoids Containing Isogenic Microglia-Like Cells. | Liu C et al. | β | 2026 | β |
| iPSC-derived microglia: Decoding roles and therapeutic opportunities in neurodegenerative diseases. | Shan D et al. | β | 2026 | β |
| Microglia-associated progression of multiple sclerosis: target identification and therapeutic engagement in human in vitro models. | Blenkle A et al. | β | 2026 | β |
| Microglia in systemic neuroimmune communication: functions beyond phagocytosis. | Di Pietro AA et al. | β | 2026 | β |
| Microglia replacement by ER-Hoxb8 conditionally immortalized macrophages provides insight into Aicardi-GoutiΓ¨res syndrome neuropathology. | Nemec KM et al. | β | 2026 | β |
| microRNA-132 attenuates inflammation in induced pluripotent stem cell-derived microglia from Alzheimer's disease patients. | Penning A et al. | β | 2026 | β |
| Navigating the frontier of human microglia isolation-standardization and translational insight. | Pal P et al. | β | 2026 | β |
| Primary Human Reactive Microglia Display Mitochondrial Dysfunction and Metabolic Imbalance Upon Lipopolysaccharide Exposure. | Fontes G et al. | β | 2026 | β |
| Synaptic effects of interleukin-6 on human iPSC-derived dopaminergic neurons. | Huang Y et al. | β | 2026 | β |
| A Comprehensive Review on Utilizing Human Brain Organoids to Study Neuroinflammation in Neurological Disorders. | Rubio AD et al. | β | 2025 | β |
| Advancements in Immunity and Dementia Research: Highlights from the 2023 AAIC Advancements: Immunity Conference. | Kloske CM et al. | β | 2025 | β |
| [Application of neural organoids containing microglia to neurodegenerative disease research]. | Harada K et al. | β | 2025 | β |
| A Xeno-Free Protocol for Rapid Differentiation of Human iPSC-Derived Microglia from the KOLF2.1J Reference Line. | Oliveira NAJ et al. | β | 2025 | β |
| Brain-wide microglia replacement using a nonconditioning strategy ameliorates pathology in mouse models of neurological disorders. | Chen D et al. | β | 2025 | β |
| Chimeric human organoid and mouse brain slice co-cultures to study microglial function. | Panagiotakopoulou V et al. | β | 2025 | β |
| Current Development of iPSC-Based Modeling in Neurodegenerative Diseases. | Guo X et al. | β | 2025 | β |
| Current Position and Future Direction of Inflammation in Neuropsychiatric Disorders: A Review. | Upthegrove R et al. | β | 2025 | β |
| Decoding microglial functions in Alzheimer's disease: insights from human models. | Rao C et al. | β | 2025 | β |
| Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes. | Guo JL et al. | β | 2025 | β |
| Development and characterization of in vitro inducible immortalization of a murine microglia cell line for high throughput studies. | Yeh H et al. | β | 2025 | β |
| Differential Responses of Human iPSC-Derived Microglia to Stimulation with Diverse Inflammogens. | Wolfbeisz C et al. | β | 2025 | β |
| Dysregulated Expression of Inflammasome and Extracellular Matrix Genes in <i>C9orf72</i>-ALS/FTD Microglia. | Thiry L et al. | β | 2025 | β |
| Electrode- and Label-Free Assessment of Electrophysiological Firing Rates through Cytochrome C Monitoring via Raman Spectroscopy. | Tentellino C et al. | β | 2025 | β |
| Emerging Insights into Brain Inflammation: Stem-Cell-Based Approaches for Regenerative Medicine. | Karam M et al. | β | 2025 | β |
| Expanding the neuroimmune research toolkit with in vivo brain organoid technologies. | Tian A et al. | β | 2025 | β |
| Human iPSC-Derived Microglia Integrate Into Cerebral Organoids and Assume an InΒ Vivo-Like Phenotype. | Wogram E et al. | β | 2025 | β |
| Human Microglia Models for NeuroHIV. | Sarkar P et al. | β | 2025 | β |
| Human oligodendrocyte progenitor cells mediate synapse elimination through TAM receptor activation. | Gkogka A et al. | β | 2025 | β |
| Induced Microglial-like Cells Derived from Familial and Sporadic Alzheimer's Disease Peripheral Blood Monocytes Show Abnormal Phagocytosis and Inflammatory Response to PSEN1 E280A Cholinergic-like Neurons. | Soto-Mercado V et al. | β | 2025 | β |
| Induced pluripotent stem cell-derived macrophages as a platform for modelling human disease. | Tiwari SK et al. | β | 2025 | β |
| Inflammatory responses revealed through HIV infection of microglia-containing cerebral organoids. | Narasipura SD et al. | β | 2025 | β |
| Integration and functionality of human iPSC-derived microglia in a chimeric mouse retinal model. | Tang C et al. | β | 2025 | β |
| Intestinal neuron-associated macrophages in health and disease. | Stakenborg N et al. | β | 2025 | β |
| In vitro models of microglia: a comparative study. | Woolf Z et al. | β | 2025 | β |
| iPSC-derived T cells and macrophages: Manufacturing and next-generation application approaches. | BasΓlio-QueirΓ³s D et al. | β | 2025 | β |
| Iterative transcription factor screening enables rapid generation of microglia-like cells from human iPSC. | Liu S et al. | β | 2025 | β |
| Lessons from ex vivo and in vitro models in microglia research. | CserΓ©p C et al. | β | 2025 | β |
| LncRNA Tug1 Regulates Post-Stroke Microglial Pyroptosis via PINK1/Parkin-Mediated Mitophagy. | Yao M et al. | β | 2025 | β |
| LRRK2 kinase activity regulates Parkinson's disease-relevant lipids at the lysosome. | Maloney MT et al. | β | 2025 | β |
| <i>SAMHD1</i> knockout hiPSC model enables high lentiviral transduction efficiency in myeloid cell types. | Li H et al. | β | 2025 | β |
| Microglia-containing neural organoids as brain microphysiological systems for long-term culture. | Rittenhouse A et al. | β | 2025 | β |
| Microglia in ALS: Insights into Mechanisms and Therapeutic Potential. | Bond S et al. | β | 2025 | β |
| Microglial Drivers of Alzheimer's Disease Pathology: AnΒ Evolution of Diverse Participating States. | Kuhn MK et al. | β | 2025 | β |
| Microglia-like cells from patient monocytes demonstrate increased phagocytic activity in probable Alzheimer's disease. | Gonul CP et al. | β | 2025 | β |
| Microglia regulate GABAergic neurogenesis in prenatal human brain through IGF1. | Yu D et al. | β | 2025 | β |
| Microglia transcriptional states and their functional significance: Context drives diversity. | Depp C et al. | β | 2025 | β |
| Modeling ALS with Patient-Derived iPSCs: Recent Advances and Future Potentials. | Dawoody Nejad L et al. | β | 2025 | β |
| Niche-specific therapeutic targeting of myeloid cells in the central nervous system. | Frosch M et al. | β | 2025 | β |
| Role of astroglia and microglia in Alzheimer's disease and multiple therapeutic interventions. | Li L et al. | β | 2025 | β |
| Single rosette-based generation of uniform cortical assembloids recapitulating cellular interactions between neurons and glial cells. | Kim E et al. | β | 2025 | β |
| The Application of iPSCs in Tumour Immunotherapy. | Chen P et al. | β | 2025 | β |
| The Rise of Pluripotent Stem Cell-Derived Glia Models of Neuroinflammation. | Kala S et al. | β | 2025 | β |
| Understanding the role of microglia in Alzheimer's disease: insights into mechanisms, acupuncture, and potential therapeutic targets. | Jinglei J et al. | β | 2025 | β |
| Advances in physiological and clinical relevance of hiPSC-derived brain models for precision medicine pipelines. | Imani Farahani N et al. | β | 2024 | β |
| An adapted protocol to derive microglia from stem cells and its application in the study of CSF1R-related disorders. | Dorion MF et al. | β | 2024 | β |
| An integrated toolkit for human microglia functional genomics. | Haq I et al. | β | 2024 | β |
| An Overview of Optic Pathway Glioma With Neurofibromatosis Type 1: Pathogenesis, Risk Factors, and Therapeutic Strategies. | Chen Y et al. | β | 2024 | β |
| APOE4/4 is linked to damaging lipid droplets in Alzheimer's diseaseΒ microglia. | Haney MS et al. | β | 2024 | β |
| Brain organoid models for studying the function of iPSC-derived microglia in neurodegeneration and brain tumours. | Sabogal-Guaqueta AM et al. | β | 2024 | β |
| Challenges and Future Perspectives in Modeling Neurodegenerative Diseases Using Organ-on-a-Chip Technology. | Pramotton FM et al. | β | 2024 | β |
| Comparison of Extracellular Vesicles from Induced Pluripotent Stem Cell-Derived Brain Cells. | Xavier G et al. | β | 2024 | β |
| Emerging Models to Study Human Microglia In vitro. | JΓ€ntti H et al. | β | 2024 | β |
| Evolution of Microglia. | Guffart E et al. | β | 2024 | β |
| Expression of ALS-PFN1 impairs vesicular degradation in iPSC-derived microglia. | Funes S et al. | β | 2024 | β |
| Glial-restricted progenitor cells: a cure for diseased brain? | Rogujski P et al. | β | 2024 | β |
| Human-induced pluripotent stem cell-derived microglia integrate into mouse retina and recapitulate features of endogenous microglia. | Ma W et al. | β | 2024 | β |
| Human liver sinusoidal endothelial cells support the development of functional human pluripotent stem cell-derived Kupffer cells. | Kent GM et al. | β | 2024 | β |
| Human otic progenitor cell models of congenital hearing loss reveal potential pathophysiologic mechanisms of Zika virus and cytomegalovirus infections. | Harding AT et al. | β | 2024 | β |
| Human pluripotent stem cell (hPSC)-derived microglia for the study of brain disorders. A comprehensive review of existing protocols. | Teo F et al. | β | 2024 | β |
| Human stem cell transplantation models of Alzheimer's disease. | Ifediora N et al. | β | 2024 | β |
| Immunologic Aspects in Fibrodysplasia Ossificans Progressiva. | Diolintzi A et al. | β | 2024 | β |
| Integration of iPSC-Derived Microglia into Brain Organoids for Neurological Research. | Mrza MA et al. | β | 2024 | β |
| Maternal SARS-CoV-2 impacts fetal placental macrophage programs and placenta-derived microglial models of neurodevelopment. | Shook LL et al. | β | 2024 | β |
| Microglia in Health and Diseases: Integrative Hubs of the Central Nervous System (CNS). | Sierra A et al. | β | 2024 | β |
| Microglia signaling in health and disease - Implications in sex-specific brain development and plasticity. | Pramanik S et al. | β | 2024 | β |
| Modeling neuropathic pain in a dish. | Zebochin I et al. | β | 2024 | β |
| Molecular Mechanisms of Rett Syndrome: Emphasizing the Roles of Monoamine, Immunity, and Mitochondrial Dysfunction. | GonΓ§alez JL et al. | β | 2024 | β |
| Multiplex Genome Editing of Human Pluripotent Stem Cells Using Cpf1. | Ma H | β | 2024 | β |
| Nanoparticle-Mediated Delivery of Anti-PU.1 siRNA via Localized Intracisternal Administration Reduces Neuroinflammation. | Ralvenius WT et al. | β | 2024 | β |
| Neuroimmune mechanisms in autism etiology - untangling a complex problem using human cellular models. | Vacharasin JM et al. | β | 2024 | β |
| Novel human iPSC models of neuroinflammation in neurodegenerative disease and regenerative medicine. | Summers RA et al. | β | 2024 | β |
| Rapid phagosome isolation enables unbiased multiomic analysis of human microglial phagosomes. | Wogram E et al. | β | 2024 | β |
| Ready-to-use iPSC-derived microglia progenitors for the treatment of CNS disease in mouse models of neuropathic mucopolysaccharidoses. | Douvaras P et al. | β | 2024 | β |
| Recapitulation and investigation of human brain development with neural organoids. | Tamada A et al. | β | 2024 | β |
| Recent advances and current challenges of new approach methodologies in developmental and adult neurotoxicity testing. | Serafini MM et al. | β | 2024 | β |
| Retinal Organoid Microenvironment Enhanced Bioactivities of Microglia-Like Cells Derived From HiPSCs. | Gao ML et al. | β | 2024 | β |
| Specificities of Living Human Microglial Cells. | Milior G et al. | β | 2024 | β |
| Stem cell engineering approaches for investigating glial cues in central nervous system disorders. | Vardhan S et al. | β | 2024 | β |
| Targeting GM2 Ganglioside Accumulation in Dementia: Current Therapeutic Approaches and Future Directions. | Kumar S et al. | β | 2024 | β |
| The ins and outs of microglial cells in brain health and disease. | PallarΓ©s-Moratalla C et al. | β | 2024 | β |
| The involvement of Ξ±-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson's disease. | Miao Y et al. | β | 2024 | β |
| The Role of Human Pluripotent Stem Cells in Amyotrophic Lateral Sclerosis: From Biological Mechanism to Practical Implications. | Ceccarelli L et al. | β | 2024 | β |
| Transcriptional characterization of iPSC-derived microglia as a model for therapeutic development in neurodegeneration. | Ramaswami G et al. | β | 2024 | β |
| Understanding Amyotrophic Lateral Sclerosis: Pathophysiology, Diagnosis, and Therapeutic Advances. | Rizea RE et al. | β | 2024 | β |
| Activation of Toll-like receptor 3 inhibits HIV infection of human iPSC-derived microglia. | Wang P et al. | β | 2023 | β |
| Advancing cell therapy for neurodegenerative diseases. | Temple S | β | 2023 | β |
| Advancing preclinical models of psychiatric disorders with human brain organoid cultures. | Dixon TA et al. | β | 2023 | β |
| Aging microglia. | Antignano I et al. | β | 2023 | β |
| Analysis of AΞ²-induced neurotoxicity and microglial responses in simple two- and three-dimensional human iPSC-derived cortical culture systems. | Takata M et al. | β | 2023 | β |
| An inΒ vivo neuroimmune organoid model to study human microglia phenotypes. | Schafer ST et al. | β | 2023 | β |
| Applications of Induced Pluripotent Stem Cell-Derived Glia in Brain Disease Research and Treatment. | Yang Z et al. | β | 2023 | β |
| Directed Differentiation of Human iPSCs into Microglia-Like Cells Using Defined Transcription Factors. | Chen SW et al. | β | 2023 | β |
| From neurodevelopment to neurodegeneration: utilizing human stem cell models to gain insight into Down syndrome. | Watson LA et al. | β | 2023 | β |
| Generation of glucocorticoid-producing cells derived from human pluripotent stem cells. | Ruiz-Babot G et al. | β | 2023 | β |
| Genetic modification of miR-34a enhances efficacy of transplanted human dental pulp stem cells after ischemic stroke. | Wang J et al. | β | 2023 | β |
| Human iPSC-derived glia models for the study of neuroinflammation. | StΓΆberl N et al. | β | 2023 | β |
| Human isogenic cells of the neurovascular unit exert transcriptomic cell type-specific effects on a blood-brain barrier in vitro model of late-onset Alzheimer disease. | Haferkamp U et al. | β | 2023 | β |
| Human microglial models to study host-virus interactions. | McMillan RE et al. | β | 2023 | β |
| Human monocyte-derived microglia-like cell models: A review of the benefits, limitations and recommendations. | Sargeant TJ et al. | β | 2023 | β |
| Hyperplastic Human Macromass Cartilage for Joint Regeneration. | Wen Y et al. | β | 2023 | β |
| Induced Pluripotent Stem Cells and Their Applications in Amyotrophic Lateral Sclerosis. | Du H et al. | β | 2023 | β |
| Leveraging iPSC technology to assess neuro-immune interactions in neurological and psychiatric disorders. | Michalski C et al. | β | 2023 | β |
| Microglia and Astrocytes in Amyotrophic Lateral Sclerosis: Disease-Associated States, Pathological Roles, and Therapeutic Potential. | You J et al. | β | 2023 | β |
| Microglia-containing cerebral organoids derived from induced pluripotent stem cells for the study of neurological diseases. | Hong Y et al. | β | 2023 | β |
| Microglia-containing human brain organoids for the study of brain development and pathology. | Zhang W et al. | β | 2023 | β |
| Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. | Gao C et al. | β | 2023 | β |
| Microglial contribution to the pathology of neurodevelopmental disorders in humans. | Matuleviciute R et al. | β | 2023 | β |
| Microglia: The breakthrough to treat neovascularization and repair blood-retinal barrier in retinopathy. | Fu X et al. | β | 2023 | β |
| Midbrain organoids-development and applications in Parkinson's disease. | Toh HSY et al. | β | 2023 | β |
| Modeling the Inflammatory Response of Traumatic Brain Injury Using Human Induced Pluripotent Stem Cell Derived Microglia. | Alam A et al. | β | 2023 | β |
| Moderate intrinsic phenotypic alterations in <i>C9orf72</i> ALS/FTD iPSC-microglia despite the presence of C9orf72 pathological features. | Lorenzini I et al. | β | 2023 | β |
| Molecular Insights into Cell Type-specific Roles in Alzheimer's Disease: Human Induced Pluripotent Stem Cell-based Disease Modelling. | Qu W et al. | β | 2023 | β |
| Neural lineage differentiation of human pluripotent stem cells: Advances in disease modeling. | Yan YW et al. | β | 2023 | β |
| 'Off the shelf' immunotherapies: Generation and application of pluripotent stem cell-derived immune cells. | Wang C et al. | β | 2023 | β |
| Opportunities and limitations for studying neuropsychiatric disorders using patient-derived induced pluripotent stem cells. | Hong Y et al. | β | 2023 | β |
| Overcoming Treatment Challenges in Posterior Segment Diseases with Biodegradable Nano-Based Drug Delivery Systems. | Wu KY et al. | β | 2023 | β |
| Recommendations, guidelines, and best practice for the use of human induced pluripotent stem cells for neuropharmacological studies of neuropsychiatric disorders. | Dutan Polit L et al. | β | 2023 | β |
| Reenacting Neuroectodermal Exposure of Hematopoietic Progenitors Enables Scalable Production of Cryopreservable iPSC-Derived Human Microglia. | Mathews M et al. | β | 2023 | β |
| Regulation of synaptic connectivity in schizophrenia spectrum by mutual neuron-microglia interaction. | Breitmeyer R et al. | β | 2023 | β |
| Role of NCKAP1 in the Defective Phagocytic Function of Microglia-Like Cells Derived from Rapidly Progressing Sporadic ALS. | Noh MY et al. | β | 2023 | β |
| Strategies for Manipulating Microglia to Determine Their Role in the Healthy and Diseased Brain. | Parajuli B et al. | β | 2023 | β |
| Targeting Neuroinflammation as Disease Modifying Approach to Alzheimer's Disease: Potential and Challenges. | Jain S et al. | β | 2023 | β |
| The Amyloid-Beta Clearance: From Molecular Targets to Glial and Neural Cells. | Cai W et al. | β | 2023 | β |
| Tools for studying human microglia: In vitro and in vivo strategies. | Warden AS et al. | β | 2023 | β |
| Toward the next generation of vascularized human neural organoids. | Li M et al. | β | 2023 | β |
| Transplanting Microglia for Treating CNS Injuries and Neurological Diseases and Disorders, and Prospects for Generating Exogenic Microglia. | Var SR et al. | β | 2023 | β |
| Tunable Conductive Hydrogel Scaffolds for Neural Cell Differentiation. | Tringides CM et al. | β | 2023 | β |
| Understanding neural development and diseases using CRISPR screens in human pluripotent stem cell-derived cultures. | Ahmed M et al. | β | 2023 | β |
| Using Stems to Bear Fruit: Deciphering the Role of Alzheimer's Disease Risk Loci in Human-Induced Pluripotent Stem Cell-Derived Microglia. | Wickstead ES | β | 2023 | β |
| A CRISPRi/a platform in human iPSC-derived microglia uncovers regulators of disease states. | DrΓ€ger NM et al. | β | 2022 | β |
| Across Dimensions: Developing 2D and 3D Human iPSC-Based Models of Fragile X Syndrome. | Lee A et al. | β | 2022 | β |
| Advanced inΒ vitro models: Microglia in action. | Cakir B et al. | β | 2022 | β |
| Advances in Recapitulating Alzheimer's Disease Phenotypes Using Human Induced Pluripotent Stem Cell-Based In Vitro Models. | Hasan MF et al. | β | 2022 | β |
| Advances in the pathogenesis of Rett syndrome using cell models. | Lu S et al. | β | 2022 | β |
| Advancing basic and translational research to deepen understanding of the molecular immune-mediated mechanisms regulating long-term persistence of HIV-1 in microglia in the adult human brain. | Boucher T et al. | β | 2022 | β |
| Animal and Cellular Models of Alzheimer's Disease: Progress, Promise, and Future Approaches. | Trujillo-Estrada L et al. | β | 2022 | β |
| Assessing human iPSC-derived microglia identity and function by immunostaining, phagocytosis, calcium activity, and inflammation assay. | HΓΌbschmann V et al. | β | 2022 | β |
| A systematic characterization of microglia-like cell occurrence during retinal organoid differentiation. | Bartalska K et al. | β | 2022 | β |
| Building in vitro models of the brain to understand the role of <i>APOE</i> in Alzheimer's disease. | Pinals RL et al. | β | 2022 | β |
| Challenges of Organoid Research. | Andrews MG et al. | β | 2022 | β |
| Chitinase-3 like-protein-1 promotes glioma progression via the NF-ΞΊB signaling pathway and tumor microenvironment reprogramming. | Zhao T et al. | β | 2022 | β |
| Comparing the Characteristics of Microglia Preparations Generated Using Different Human iPSC-Based Differentiation Methods to Model Neurodegenerative Diseases. | Tang YM et al. | β | 2022 | β |
| Current advancements of modelling schizophrenia using patient-derived induced pluripotent stem cells. | Dubonyte U et al. | β | 2022 | β |
| Deterministic programming of human pluripotent stem cells into microglia facilitates studying their role in health and disease. | Speicher AM et al. | β | 2022 | β |
| Development of prefrontal cortex. | Kolk SM et al. | β | 2022 | β |
| Dissecting the complexities of Alzheimer disease with in vitro models of the human brain. | Blanchard JW et al. | β | 2022 | β |
| Efficient and Easy Conversion of Human iPSCs into Functional Induced Microglia-like Cells. | Lanfer J et al. | β | 2022 | β |
| Elevated Ξ±-synuclein attenuates phagocytosis in<i>SNCA</i>triplication human iPSC-derived neuron:microglia co-cultures | Lieberman R et al. | β | 2022 | β |
| Emerging Role of miR-21-5p in Neuron-Glia Dysregulation and Exosome Transfer Using Multiple Models of Alzheimer's Disease. | Garcia G et al. | β | 2022 | β |
| Enhanced delivery of antibodies across the blood-brain barrier via TEMs with inherent receptor-mediated phagocytosis. | Edavettal S et al. | β | 2022 | β |
| Expression of the transcription factor PU.1 induces the generation of microglia-like cells in human cortical organoids. | Cakir B et al. | β | 2022 | β |
| Functional microglia derived from human pluripotent stem cells empower retinal organ. | Gao ML et al. | β | 2022 | β |
| Generation of vascularized brain organoids to study neurovascular interactions. | Sun XY et al. | β | 2022 | β |
| Homozygous ALS-linked FUS P525L mutations cell- autonomously perturb transcriptome profile and chemoreceptor signaling in human iPSC microglia. | Kerk SY et al. | β | 2022 | β |
| Human Brain-Based Models Provide a Powerful Tool for the Advancement of Parkinson's Disease Research and Therapeutic Development. | McComish SF et al. | β | 2022 | β |
| Human-Induced Pluripotent Stem Cell-Based Models for Studying Sex-Specific Differences in Neurodegenerative Diseases. | Kiris E | β | 2022 | β |
| Human Induced Pluripotent Stem Cell-Derived Microglia (hiPSC-Microglia). | McQuade A et al. | β | 2022 | β |
| Human iPSC co-culture model to investigate the interaction between microglia and motor neurons. | Vahsen BF et al. | β | 2022 | β |
| Human iPSC-Derived Neural Models for Studying Alzheimer's Disease: from Neural Stem Cells to Cerebral Organoids. | Barak M et al. | β | 2022 | β |
| Human microglial models to study HIV infection and neuropathogenesis: a literature overview and comparative analyses. | Gumbs SBH et al. | β | 2022 | β |
| Human Pluripotent Stem Cell Differentiation to Microglia. | Ijaz L et al. | β | 2022 | β |
| Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation. | Giacomelli E et al. | β | 2022 | β |
| Microglia and Astrocyte Function and Communication: What Do We Know in Humans? | Garland EF et al. | β | 2022 | β |
| Microglia in a Dish-Which Techniques Are on the Menu for Functional Studies? | Aktories P et al. | β | 2022 | β |
| Microglia integration into human midbrain organoids leads to increased neuronal maturation and functionality. | Sabate-Soler S et al. | β | 2022 | β |
| Microglial TREM2 in amyotrophic lateral sclerosis. | Xie M et al. | β | 2022 | β |
| Microglia modulate proliferation, neurite generation and differentiation of human neural progenitor cells. | Lilienberg J et al. | β | 2022 | β |
| Modeling and Targeting Neuroglial Interactions with Human Pluripotent Stem Cell Models. | Bigarreau J et al. | β | 2022 | β |
| Modeling Developmental Brain Diseases Using Human Pluripotent Stem Cells-Derived Brain Organoids - Progress and Perspective. | Bhattacharya A et al. | β | 2022 | β |
| Neuroimmune contributions to Alzheimer's disease: a focus on human data. | Haage V et al. | β | 2022 | β |
| Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development-Current State-of-the-Art and Future Perspectives. | Youhanna S et al. | β | 2022 | β |
| Patient-Derived InΒ Vitro Models of Microglial Function and Synaptic Engulfment in Schizophrenia. | Sheridan SD et al. | β | 2022 | β |
| PAX6-positive microglia evolve locally in hiPSC-derived ocular organoids. | Shiraki N et al. | β | 2022 | β |
| Pluripotent stem cell strategies for rebuilding the human brain. | Limone F et al. | β | 2022 | β |
| Proficiency of Extracellular Vesicles From hiPSC-Derived Neural Stem Cells in Modulating Proinflammatory Human Microglia: Role of Pentraxin-3 and miRNA-21-5p. | Upadhya R et al. | β | 2022 | β |
| Promising Strategies for the Development of Advanced In Vitro Models with High Predictive Power in Ischaemic Stroke Research. | Van Breedam E et al. | β | 2022 | β |
| Protocol to photoactivate adipose-derived stem cell differentiation using a tightly-focused femtosecond laser. | Tang W et al. | β | 2022 | β |
| Recent Advances in Microglia Modelling to Address Translational Outcomes in Neurodegenerative Diseases. | CunΓ-LΓ³pez C et al. | β | 2022 | β |
| Redefining microglia states: Lessons and limits of human and mouse models to study microglia states in neurodegenerative diseases. | Yvanka de Soysa T et al. | β | 2022 | β |
| Resident Macrophages and Their Potential in Cardiac Tissue Engineering. | Suku M et al. | β | 2022 | β |
| Single-cell transcriptomics defines an improved, validated monoculture protocol for differentiation of human iPSC to microglia. | Washer SJ et al. | β | 2022 | β |
| Single transcription factor efficiently leads human induced pluripotent stem cells to functional microglia. | Sonn I et al. | β | 2022 | β |
| Stable expression of a truncated TLX variant drives differentiation of induced pluripotent stem cells into self-renewing neural stem cells for production of extracellular vesicles. | Xu M et al. | β | 2022 | β |
| Stem cell-based region-specific brain organoids: Novel models to understand neurodevelopmental defects. | Shafique S | β | 2022 | β |
| Targeting Microglia in Alzheimer's Disease: From Molecular Mechanisms to Potential Therapeutic Targets for Small Molecules. | Althafar ZM | β | 2022 | β |
| The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases. | Zang X et al. | β | 2022 | β |
| The heterogeneity of microglial activation and its epigenetic and non-coding RNA regulations in the immunopathogenesis of neurodegenerative diseases. | Li C et al. | β | 2022 | β |
| Tissue-Engineered Models of the Human Brain: State-of-the-Art Analysis and Challenges. | Tarricone G et al. | β | 2022 | β |
| Using MS induced pluripotent stem cells to investigate MS aetiology. | Fortune AJ et al. | β | 2022 | β |
| A Core Transcription Regulatory Circuitry Defining Microglia Cell Identity Inferred from the Reanalysis of Multiple Human Microglia Differentiation Protocols. | Aubert A et al. | β | 2021 | β |
| ACVR1<sup>R206H</sup> extends inflammatory responses in human induced pluripotent stem cell-derived macrophages. | Matsuo K et al. | β | 2021 | β |
| Advances in Central Nervous System Organoids: A Focus on Organoid-Based Models for Motor Neuron Disease. | Vieira de SΓ‘ R et al. | β | 2021 | β |
| Aged Microglia in Neurodegenerative Diseases: Microglia Lifespan and Culture Methods. | Yoo HJ et al. | β | 2021 | β |
| A map of transcriptional heterogeneity and regulatory variation in human microglia. | Young AMH et al. | β | 2021 | β |
| A new method for obtaining bankable and expandable adult-like microglia in mice. | You MJ et al. | β | 2021 | β |
| Application of Patient-Specific iPSCs for Modelling and Treatment of X-Linked Cardiomyopathies. | Zhang J et al. | β | 2021 | β |
| Applying stem cells and CRISPR engineering to uncover the etiology of schizophrenia. | Michael Deans PJ et al. | β | 2021 | β |
| Astrocytes and microglia in neurodegenerative diseases: Lessons from human in vitro models. | Franklin H et al. | β | 2021 | β |
| Brain Organoids: Studying Human Brain Development and Diseases in a Dish. | Xu J et al. | β | 2021 | β |
| Building the brain from scratch: Engineering region-specific brain organoids from human stem cells to study neural development and disease. | Jacob F et al. | β | 2021 | β |
| Cell Fate Reprogramming in the Era of Cancer Immunotherapy. | Zimmermannova O et al. | β | 2021 | β |
| Cellular complexity in brain organoids: Current progress and unsolved issues. | Mansour AA et al. | β | 2021 | β |
| Cerebral Organoids-Challenges to Establish a Brain Prototype. | Eremeev AV et al. | β | 2021 | β |
| Co-Culturing Microglia and Cortical Neurons Differentiated from Human Induced Pluripotent Stem Cells. | Lopez-Lengowski K et al. | β | 2021 | β |
| Comparative Review of Microglia and Monocytes in CNS Phagocytosis. | Andoh M et al. | β | 2021 | β |
| Contribution of Human Pluripotent Stem Cell-Based Models to Drug Discovery for Neurological Disorders. | Benchoua A et al. | β | 2021 | β |
| Current Methods for the Isolation and Cultivation of Microglia (Review). | Malinovskaya NA et al. | β | 2021 | β |
| Current tools to interrogate microglial biology. | Dumas AA et al. | β | 2021 | β |
| Detection and Functional Evaluation of the P2X7 Receptor in hiPSC Derived Neurons and Microglia-Like Cells. | FrancistiovΓ‘ L et al. | β | 2021 | β |
| Developing human pluripotent stem cell-based cerebral organoids with a controllable microglia ratio for modeling brain development and pathology. | Xu R et al. | β | 2021 | β |
| Dissecting the non-neuronal cell contribution to Parkinson's disease pathogenesis using induced pluripotent stem cells. | Pons-Espinal M et al. | β | 2021 | β |
| Efficient conversion of human induced pluripotent stem cells into microglia by defined transcription factors. | Chen SW et al. | β | 2021 | β |
| Efficient induction of neural progenitor cells from human ESC/iPSCs on Type I Collagen. | Liu P et al. | β | 2021 | β |
| Emerging hiPSC Models for Drug Discovery in Neurodegenerative Diseases. | Trudler D et al. | β | 2021 | β |
| Epigenetic regulation during human cortical development: Seq-ing answers from the brain to the organoid. | Lewis EMA et al. | β | 2021 | β |
| Evolution of adrenoleukodystrophy model systems. | Montoro R et al. | β | 2021 | β |
| Evolving Models and Tools for Microglial Studies in the Central Nervous System. | Zhang Y et al. | β | 2021 | β |
| Exploiting dynamic enhancer landscapes to decode macrophage and microglia phenotypes in health and disease. | Troutman TD et al. | β | 2021 | β |
| Fully defined human pluripotent stem cell-derived microglia and tri-culture system model C3 production in Alzheimer's disease. | Guttikonda SR et al. | β | 2021 | β |
| Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies. | McTague A et al. | β | 2021 | β |
| Growing Glia: Cultivating Human Stem Cell Models of Gliogenesis in Health and Disease. | Lanjewar SN et al. | β | 2021 | β |
| Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology. | KΓΌhn R et al. | β | 2021 | β |
| Human iPSC-Derived Glia as a Tool for Neuropsychiatric Research and Drug Development. | Heider J et al. | β | 2021 | β |
| Human physiomimetic model integrating microphysiological systems of the gut, liver, and brain for studies of neurodegenerative diseases. | Trapecar M et al. | β | 2021 | β |
| Human stem cell models to study host-virus interactions in the central nervous system. | Harschnitz O et al. | β | 2021 | β |
| Interplay Between Microglia and Alzheimer's Disease-Focus on the Most Relevant Risks: APOE Genotype, Sex and Age. | Chen Y et al. | β | 2021 | β |
| Involvement of Microglia in the Pathophysiology of Intracranial Aneurysms and Vascular Malformations-A Short Overview. | Timis TL et al. | β | 2021 | β |
| Microglia and Central Nervous System-Associated Macrophages-From Origin to Disease Modulation. | Prinz M et al. | β | 2021 | β |
| Microglia Development and Maturation and Its Implications for Induction of Microglia-Like Cells from Human iPSCs. | Wurm J et al. | β | 2021 | β |
| Microglia in Alzheimer's Disease: A Target for Therapeutic Intervention. | Zhang G et al. | β | 2021 | β |
| Microglial innate memory and epigenetic reprogramming in neurological disorders. | Martins-Ferreira R et al. | β | 2021 | β |
| Modeling Neurological Disorders in 3D Organoids Using Human-Derived Pluripotent Stem Cells. | Bose R et al. | β | 2021 | β |
| Modelling neurodegenerative disease using brain organoids. | Wray S | β | 2021 | β |
| Mood Stabilizers in Psychiatric Disorders and Mechanisms Learnt from In Vitro Model Systems. | Nayak R et al. | β | 2021 | β |
| Multifaceted involvement of microglia in gray matter pathology in multiple sclerosis. | Tsouki F et al. | β | 2021 | β |
| Neural In Vitro Models for Studying Substances Acting on the Central Nervous System. | Fritsche E et al. | β | 2021 | β |
| [New technologies to unveil the role of brain glial cells]. | Hemonnot-Girard AL et al. | β | 2021 | β |
| Next-Generation Human Cerebral Organoids as Powerful Tools To Advance NeuroHIV Research. | Premeaux TA et al. | β | 2021 | β |
| Novel Scalable and Simplified System to Generate Microglia-Containing Cerebral Organoids From Human Induced Pluripotent Stem Cells. | Bodnar B et al. | β | 2021 | β |
| Oligodendrocytes and Microglia: Key Players in Myelin Development, Damage and Repair. | Kalafatakis I et al. | β | 2021 | β |
| Peroxisomal ABC Transporters: An Update. | Tawbeh A et al. | β | 2021 | β |
| Physiology of Cultured Human Microglia Maintained in a Defined Culture Medium. | Tewari M et al. | β | 2021 | β |
| Quantitative morphometric and cell-type-specific population analysis of microglia-enriched cultures subcloned to high purity from newborn rat brains. | Dulka K et al. | β | 2021 | β |
| Redefining Microglial Identity in Health and Disease at Single-Cell Resolution. | Provenzano F et al. | β | 2021 | β |
| Role of Microglia and Astrocytes in Spinal Cord Injury Induced Neuropathic Pain. | Miranpuri GS et al. | β | 2021 | β |
| Roles of microglia in Alzheimer's disease and impact of new findings on microglial heterogeneity as a target for therapeutic intervention. | Takata K et al. | β | 2021 | β |
| Soluble Ξ±-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia. | Trudler D et al. | β | 2021 | β |
| Stem Cells for Next Level Toxicity Testing in the 21st Century. | Fritsche E et al. | β | 2021 | β |
| Strategies and Tools for Studying Microglial-Mediated Synapse Elimination and Refinement. | Morini R et al. | β | 2021 | β |
| The Application of Brain Organoid Technology in Stroke Research: Challenges and Prospects. | Song G et al. | β | 2021 | β |
| The emerging tale of microglia in psychiatric disorders. | Rahimian R et al. | β | 2021 | β |
| The influence of the R47H triggering receptor expressed on myeloid cells 2 variant on microglial exosome profiles. | Mallach A et al. | β | 2021 | β |
| The Path to Progress Preclinical Studies of Age-Related Neurodegenerative Diseases: A Perspective on Rodent and hiPSC-Derived Models. | MacDougall G et al. | β | 2021 | β |
| The road to restore vision with photoreceptor regeneration. | Zhang CJ et al. | β | 2021 | β |
| The role of hypoxia in stem cell regulation of the central nervous system: From embryonic development to adult proliferation. | Li G et al. | β | 2021 | β |
| Three-dimensional in vitro tissue culture models of brain organoids. | Gong J et al. | β | 2021 | β |
| Transnasal transplantation of human induced pluripotent stem cell-derived microglia to the brain of immunocompetent mice. | Parajuli B et al. | β | 2021 | β |
| Validation of Induced Microglia-Like Cells (iMG Cells) for Future Studies of Brain Diseases. | Banerjee A et al. | β | 2021 | β |
| A CX3CR1 Reporter hESC Line Facilitates Integrative Analysis of In-Vitro-Derived Microglia and Improved Microglia Identity upon Neuron-Glia Co-culture. | Grubman A et al. | β | 2020 | β |
| A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC-derived microglia. | Piers TM et al. | β | 2020 | β |
| Alzheimer's-associated PLCΞ³2 is a signaling node required for both TREM2 function and the inflammatory response in human microglia. | Andreone BJ et al. | β | 2020 | β |
| Alzheimer's Risk Gene TREM2 Determines Functional Properties of New Type of Human iPSC-Derived Microglia. | Reich M et al. | β | 2020 | β |
| Applying hiPSCs and Biomaterials Towards an Understanding and Treatment of Traumatic Brain Injury. | Lacalle-Aurioles M et al. | β | 2020 | β |
| Brain Parenchymal and Extraparenchymal Macrophages in Development, Homeostasis, and Disease. | Brioschi S et al. | β | 2020 | β |
| Cell Type-Specific Intralocus Interactions Reveal Oligodendrocyte Mechanisms in MS. | Factor DC et al. | β | 2020 | β |
| Cerebral organoids: emerging ex vivo humanoid models of glioblastoma. | Papaioannou MD et al. | β | 2020 | β |
| Challenges in Modeling Human Neural Circuit Formation via Brain Organoid Technology. | Matsui TK et al. | β | 2020 | β |
| Chimeras for the twenty-first century. | Morata Tarifa C et al. | β | 2020 | β |
| Comparative analysis of human microglial models for studies of HIV replication and pathogenesis. | Rai MA et al. | β | 2020 | β |
| Crosstalk Between Astrocytes and Microglia: An Overview. | Matejuk A et al. | β | 2020 | β |
| Do not keep it simple: recent advances in the generation of complex organoids. | WΓΆrsdΓΆrfer P et al. | β | 2020 | β |
| Efficient Strategies for Microglia Replacement in the Central Nervous System. | Xu Z et al. | β | 2020 | β |
| Emerging Developments in Human Induced Pluripotent Stem Cell-Derived Microglia: Implications for Modelling Psychiatric Disorders With a Neurodevelopmental Origin. | Hanger B et al. | β | 2020 | β |
| Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer's Disease. | Lewcock JW et al. | β | 2020 | β |
| Emerging technologies to study glial cells. | Hirbec H et al. | β | 2020 | β |
| Engineered tissues and strategies to overcome challenges in drug development. | Khalil AS et al. | β | 2020 | β |
| Functional analysis of CX3CR1 in human induced pluripotent stem (iPS) cell-derived microglia-like cells. | Murai N et al. | β | 2020 | β |
| Functional genomics, genetic risk profiling and cell phenotypes in neurodegenerative disease. | Finkbeiner S | β | 2020 | β |
| Generation and Functional Characterization of Monocytes and Macrophages Derived from Human Induced Pluripotent Stem Cells. | Cao X et al. | β | 2020 | β |
| Gene Therapy in the Management of Parkinson's Disease: Potential of GDNF as a Promising Therapeutic Strategy. | Behl T et al. | β | 2020 | β |
| Genetic predispositions of Parkinson's disease revealed in patient-derived brain cells. | Tran J et al. | β | 2020 | β |
| Glia in Neurodegeneration: The Housekeeper, the Defender and the Perpetrator. | Sheeler C et al. | β | 2020 | β |
| Harnessing the anti-inflammatory properties of stem cells for transplant therapy in hemorrhagic stroke. | Corey S et al. | β | 2020 | β |
| High-Fidelity Modeling of Human Microglia with Pluripotent Stem Cells. | Jiang P et al. | β | 2020 | β |
| HIV-1 Persistence and Chronic Induction of Innate Immune Responses in Macrophages. | Akiyama H et al. | β | 2020 | β |
| Honing the Double-Edged Sword: Improving Human iPSC-Microglia Models. | Hedegaard A et al. | β | 2020 | β |
| Human-induced pluripotent stem cells as a model for studying sporadic Alzheimer's disease. | Riemens RJM et al. | β | 2020 | β |
| Human in vitro models for understanding mechanisms of autism spectrum disorder. | Gordon A et al. | β | 2020 | β |
| Human iPSC-derived mature microglia retain their identity and functionally integrate in the chimeric mouse brain. | Xu R et al. | β | 2020 | β |
| Human iPSC-derived microglia: A growing toolset to study the brain's innate immune cells. | Hasselmann J et al. | β | 2020 | β |
| Human pluripotent stem cell-derived models and drug screening in CNS precision medicine. | Silva MC et al. | β | 2020 | β |
| Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer's Disease. | Garcia-Leon JA et al. | β | 2020 | β |
| Immovable Object Meets Unstoppable Force? Dialogue Between Resident and Peripheral Myeloid Cells in the Inflamed Brain. | Spiteri AG et al. | β | 2020 | β |
| Integrating CRISPR Engineering and hiPSC-Derived 2D Disease Modeling Systems. | Rehbach K et al. | β | 2020 | β |
| iPSC-Derived Microglia for Modeling Human-Specific DAMP and PAMP Responses in the Context of Alzheimer's Disease. | Ihnatovych I et al. | β | 2020 | β |
| Label-free adaptive optics imaging of human retinal macrophage distribution and dynamics. | Hammer DX et al. | β | 2020 | β |
| Leveraging preclinical models for the development of Alzheimer disease therapeutics. | Scearce-Levie K et al. | β | 2020 | β |
| Microglia: Agents of the CNS Pro-Inflammatory Response. | RodrΓguez-GΓ³mez JA et al. | β | 2020 | β |
| Microglia Diversity in Health and Multiple Sclerosis. | Zia S et al. | β | 2020 | β |
| Microglial ontogeny, diversity and neurodevelopmental functions. | Thion MS et al. | β | 2020 | β |
| Microglial phagocytosis in aging and Alzheimer's disease. | GabandΓ©-RodrΓguez E et al. | β | 2020 | β |
| Microglia promote glioblastoma via mTOR-mediated immunosuppression of the tumour microenvironment. | Dumas AA et al. | β | 2020 | β |
| Microtechnology-based methods for organoid models. | Velasco V et al. | β | 2020 | β |
| Midbrain Organoids: A New Tool to Investigate Parkinson's Disease. | Smits LM et al. | β | 2020 | β |
| Modeling Alzheimer's disease with iPSC-derived brain cells. | Penney J et al. | β | 2020 | β |
| Modeling neuropsychiatric disorders using human induced pluripotent stem cells. | Wang M et al. | β | 2020 | β |
| Modeling Psychiatric Disorder Biology with Stem Cells. | Das D et al. | β | 2020 | β |
| Modelling multiple sclerosis using induced pluripotent stem cells. | MartΓnez-Larrosa J et al. | β | 2020 | β |
| Parkinson's Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy? | Gundersen V | β | 2020 | β |
| Patient-Derived Midbrain Organoids to Explore the Molecular Basis of Parkinson's Disease. | Galet B et al. | β | 2020 | β |
| Proteome-Scale Mapping of Perturbed Proteostasis in Living Cells. | Lam I et al. | β | 2020 | β |
| Review of functional in vitro models of the blood-cerebrospinal fluid barrier in leukaemia research. | Erb U et al. | β | 2020 | β |
| Role of microglia in the dissemination of Zika virus from mother to fetal brain. | Xu P et al. | β | 2020 | β |
| Stage-specific regulation of Gremlin1 on the differentiation and expansion of human urinary induced pluripotent stem cells into endothelial progenitors. | Chen H et al. | β | 2020 | β |
| Studying Human Neurodevelopment and Diseases Using 3D Brain Organoids. | Tian A et al. | β | 2020 | β |
| The Genetic Relevance of Human Induced Pluripotent Stem Cell-Derived Microglia to Alzheimer's Disease and Major Neuropsychiatric Disorders. | Butler Iii RR et al. | β | 2020 | β |
| The influence of environment and origin on brain resident macrophages and implications for therapy. | Bennett ML et al. | β | 2020 | β |
| TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge. | Nugent AA et al. | β | 2020 | β |
| Upgrading the Physiological Relevance of Human Brain Organoids. | Del Dosso A et al. | β | 2020 | β |
| Using Two- and Three-Dimensional Human iPSC Culture Systems to Model Psychiatric Disorders. | Christian KM et al. | β | 2020 | β |
| When glia meet induced pluripotent stem cells (iPSCs). | Li L et al. | β | 2020 | β |
| All Together Now: Modeling the Interaction of Neural With Non-neural Systems Using Organoid Models. | Chukwurah E et al. | β | 2019 | β |
| Alzheimer's Disease Research Using Human Microglia. | Lue LF et al. | β | 2019 | β |
| ApoE4-Induced Cholesterol Dysregulation and Its Brain Cell Type-Specific Implications in the Pathogenesis of Alzheimer's Disease. | Jeong W et al. | β | 2019 | β |
| Astrocytes and microglia: Models and tools. | Guttenplan KA et al. | β | 2019 | β |
| Biologically inspired approaches to enhance human organoid complexity. | Holloway EM et al. | β | 2019 | β |
| Brain organoids: a next step for humanized Alzheimer's disease models? | Gerakis Y et al. | β | 2019 | β |
| Brain Organoids as Tools for Modeling Human Neurodevelopmental Disorders. | Adams JW et al. | β | 2019 | β |
| Cien AΓ±os de MicroglΓa: Milestones in a Century of Microglial Research. | Sierra A et al. | β | 2019 | β |
| Concise Review: Modeling Neurodegenerative Diseases with Human Pluripotent Stem Cell-Derived Microglia. | Haenseler W et al. | β | 2019 | β |
| Constructing and Deconstructing Cancers using Human Pluripotent Stem Cells and Organoids. | Smith RC et al. | β | 2019 | β |
| Differentiation of Human-Induced Pluripotent Stem Cells to Macrophages for Disease Modeling and Functional Genomics. | Shi J et al. | β | 2019 | β |
| Enforced microglial depletion and repopulation as a promising strategy for the treatment of neurological disorders. | Han J et al. | β | 2019 | β |
| Engineering Microfluidic Organoid-on-a-Chip Platforms. | Yu F et al. | β | 2019 | β |
| Exosomes from Microglia Attenuate Photoreceptor Injury and Neovascularization in an Animal Model of Retinopathy of Prematurity. | Xu W et al. | β | 2019 | β |
| From Schizophrenia Genetics to Disease Biology: Harnessing New Concepts and Technologies. | Duan J et al. | β | 2019 | β |
| Functionalization of Brain Region-specific Spheroids with Isogenic Microglia-like Cells. | Song L et al. | β | 2019 | β |
| Generating microglia from human pluripotent stem cells: novel in vitro models for the study of neurodegeneration. | Speicher AM et al. | β | 2019 | β |
| Genome-wide CRISPR screen for Zika virus resistance in human neural cells. | Li Y et al. | β | 2019 | β |
| Genomics Analysis of Metabolic Pathways of Human Stem Cell-Derived Microglia-Like Cells and the Integrated Cortical Spheroids. | Bejoy J et al. | β | 2019 | β |
| Glial Dysfunction in MeCP2 Deficiency Models: Implications for Rett Syndrome. | Kahanovitch U et al. | β | 2019 | β |
| Human-induced pluripotent stem cell-derived blood products: state of the art and future directions. | Hansen M et al. | β | 2019 | β |
| Human iPSC application in Alzheimer's disease and Tau-related neurodegenerative diseases. | Tcw J | β | 2019 | β |
| Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain. | Svoboda DS et al. | β | 2019 | β |
| Human stem cell-derived monocytes and microglia-like cells reveal impaired amyloid plaque clearance upon heterozygous or homozygous loss of TREM2. | Claes C et al. | β | 2019 | β |
| Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning. | Sellgren CM et al. | β | 2019 | β |
| iPSCs-Based Neural 3D Systems: A Multidimensional Approach for Disease Modeling and Drug Discovery. | Costamagna G et al. | β | 2019 | β |
| Macrophages at CNS interfaces: ontogeny and function in health andΒ disease. | Kierdorf K et al. | β | 2019 | β |
| Microglia Biology: One Century of Evolving Concepts. | Prinz M et al. | β | 2019 | β |
| Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities. | Hemonnot AL et al. | β | 2019 | β |
| Microglia in Alzheimer's Disease: Exploring How Genetics and Phenotype Influence Risk. | McQuade A et al. | β | 2019 | β |
| Microglia Reactivity: Heterogeneous Pathological Phenotypes. | Hirbec H et al. | β | 2019 | β |
| Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders. | Kim Y et al. | β | 2019 | β |
| Modeling Alzheimer's disease with human iPS cells: advancements, lessons, and applications. | Essayan-Perez S et al. | β | 2019 | β |
| Modeling Brain Somatic Mosaicism With Cerebral Organoids, Including a Note on Mutant Microglia. | Verheijen BM | β | 2019 | β |
| Modeling Cell-Cell Interactions in Parkinson's Disease Using Human Stem Cell-Based Models. | Simmnacher K et al. | β | 2019 | β |
| Modeling cell-cell interactions in the brain using cerebral organoids. | Oliveira B et al. | β | 2019 | β |
| Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells. | Naphade S et al. | β | 2019 | β |
| Nanostructured Modulators of Neuroglia. | Maysinger D et al. | β | 2019 | β |
| Optic Pathway Glioma in Type 1 Neurofibromatosis: Review of Its Pathogenesis, Diagnostic Assessment, and Treatment Recommendations. | Cassina M et al. | β | 2019 | β |
| Pathological Changes in Alzheimer's Disease Analyzed Using Induced Pluripotent Stem Cell-Derived Human Microglia-Like Cells. | Xu M et al. | β | 2019 | β |
| PSEN1ΞE9, APPswe, and APOE4 Confer Disparate Phenotypes in Human iPSC-Derived Microglia. | Konttinen H et al. | β | 2019 | β |
| Regulation of Microglia Identity from an Epigenetic and Transcriptomic Point of View. | Eggen BJL et al. | β | 2019 | β |
| Reverse genetic screen reveals that Il34 facilitates yolk sac macrophage distribution and seeding of the brain. | Kuil LE et al. | β | 2019 | β |
| Role of Microglia in Ataxias. | Ferro A et al. | β | 2019 | β |
| Special issue on stem cell and tissue engineering in development, disease, and repair. | Shcheglovitov A et al. | β | 2019 | β |
| Studying Heterotypic Cellβ»Cell Interactions in the Human Brain Using Pluripotent Stem Cell Models for Neurodegeneration. | Song L et al. | β | 2019 | β |
| Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models. | Logan S et al. | β | 2019 | β |
| Targeted Gene Editing of Glia Maturation Factor in Microglia: a Novel Alzheimer's Disease Therapeutic Target. | Raikwar SP et al. | β | 2019 | β |
| The A1 astrocyte paradigm: New avenues for pharmacological intervention in neurodegeneration. | Hinkle JT et al. | β | 2019 | β |
| The pro-remyelination properties of microglia in the central nervous system. | Lloyd AF et al. | β | 2019 | β |
| Transcriptional and Epigenetic Regulation of Microglia in Health and Disease. | Yeh H et al. | β | 2019 | β |
| Use of human pluripotent stem cell-derived cells for neurodegenerative disease modeling and drug screening platform. | Garcia-Leon JA et al. | β | 2019 | β |
| 3D human brain cell models: New frontiers in disease understanding and drug discovery for neurodegenerative diseases. | Korhonen P et al. | β | 2018 | β |
| Advances in Drug Discovery and Development in Geriatric Psychiatry. | C Conley A et al. | β | 2018 | β |
| An Overview of <i>in vitro</i> Methods to Study Microglia. | Timmerman R et al. | β | 2018 | β |
| APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer's Disease Phenotypes in Human iPSC-Derived Brain Cell Types. | Lin YT et al. | β | 2018 | β |
| A transcriptomic atlas of aged human microglia. | Olah M et al. | β | 2018 | β |
| Author Correction: Genetically engineered cerebral organoids model brain tumor formation. | Bian S et al. | β | 2018 | β |
| Best Practices for Translational Disease Modeling Using Human iPSC-Derived Neurons. | Engle SJ et al. | β | 2018 | β |
| Bone-Marrow-Derived Microglia-Like Cells Ameliorate Brain Amyloid Pathology and Cognitive Impairment in a Mouse Model of Alzheimer's Disease. | Kawanishi S et al. | β | 2018 | β |
| Brain organoids as models to study human neocortex development and evolution. | Heide M et al. | β | 2018 | β |
| Cell reprogramming approaches in gene- and cell-based therapies for Parkinson's disease. | Man JHK et al. | β | 2018 | β |
| Central Nervous System Responses to Simulated Galactic Cosmic Rays. | Cekanaviciute E et al. | β | 2018 | β |
| Development and validation of a simplified method to generate human microglia from pluripotent stem cells. | McQuade A et al. | β | 2018 | β |
| Differentiation of Glial Cells From hiPSCs: Potential Applications in Neurological Diseases and Cell Replacement Therapy. | Zheng W et al. | β | 2018 | β |
| Effective Knockdown of Gene Expression in Primary Microglia With siRNA and Magnetic Nanoparticles Without Cell Death or Inflammation. | Carrillo-Jimenez A et al. | β | 2018 | β |
| Functional Studies of Missense TREM2 Mutations in Human Stem Cell-Derived Microglia. | Brownjohn PW et al. | β | 2018 | β |
| Generating tissue-resident macrophages from pluripotent stem cells: Lessons learned from microglia. | Claes C et al. | β | 2018 | β |
| Generation of defined neural populations from pluripotent stem cells. | McComish SF et al. | β | 2018 | β |
| Genetically engineered cerebral organoids model brain tumor formation. | Bian S et al. | β | 2018 | β |
| Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells? | Prytkova I et al. | β | 2018 | β |
| Genome engineering for CNS injury and disease. | Pardieck J et al. | β | 2018 | β |
| Human fibroblast and stem cell resource from the Dominantly Inherited Alzheimer Network. | Karch CM et al. | β | 2018 | β |
| Human induced pluripotent stem cell-derived glial cells and neural progenitors display divergent responses to Zika and dengue infections. | Muffat J et al. | β | 2018 | β |
| Human Induced Pluripotent Stem Cell-Derived Microglia-Like Cells Harboring TREM2 Missense Mutations Show Specific Deficits in Phagocytosis. | Garcia-Reitboeck P et al. | β | 2018 | β |
| Human stem cell modeling in neurofibromatosis type 1 (NF1). | Wegscheid ML et al. | β | 2018 | β |
| Identification of glia phenotype modulators based on select glial function regulatory signaling pathways. | Lee SH et al. | β | 2018 | β |
| Increased Microglial CSF1R Expression in the SIV/Macaque Model of HIV CNS Disease. | Knight AC et al. | β | 2018 | β |
| Induced Pluripotent Stem Cells: A Powerful Neurodegenerative Disease Modeling Tool for Mechanism Study and Drug Discovery. | Chang CY et al. | β | 2018 | β |
| Induced pluripotent stem cells (iPSCs) as model to study inherited defects of neurotransmission in inborn errors of metabolism. | Jung-Klawitter S et al. | β | 2018 | β |
| Inducible CRISPR genome editing platform in naive human embryonic stem cells reveals JARID2 function in self-renewal. | Ferreccio A et al. | β | 2018 | β |
| iPS cells in the study of PD molecular pathogenesis. | Cobb MM et al. | β | 2018 | β |
| Isolation and Phenotyping of Adult Mouse Microglial Cells. | Grabert K et al. | β | 2018 | β |
| Is Parkinson's Disease a Neurodevelopmental Disorder and Will Brain Organoids Help Us to Understand It? | Schwamborn JC | β | 2018 | β |
| Mechanisms of dietary flavonoid action in neuronal function and neuroinflammation. | Jaeger BN et al. | β | 2018 | β |
| Method for High Speed Stretch Injury of Human Induced Pluripotent Stem Cell-derived Neurons in a 96-well Format. | Phillips JK et al. | β | 2018 | β |
| Microcephaly Modeling of Kinetochore Mutation Reveals a Brain-Specific Phenotype. | Omer Javed A et al. | β | 2018 | β |
| Microglia and macrophages in brain homeostasis and disease. | Li Q et al. | β | 2018 | β |
| Microglia and the Brain: Complementary Partners in Development and Disease. | Hammond TR et al. | β | 2018 | β |
| Microglia in Alzheimer's Disease: A Role for Ion Channels. | Thei L et al. | β | 2018 | β |
| Microglia Increase Inflammatory Responses in iPSC-Derived Human BrainSpheres. | Abreu CM et al. | β | 2018 | β |
| Microglia innately develop within cerebral organoids. | Ormel PR et al. | β | 2018 | β |
| Microglia in neurodegeneration. | Hickman S et al. | β | 2018 | β |
| Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential. | Inoue K et al. | β | 2018 | β |
| Microglia in the CNS and Neuropathic Pain. | Tsuda M | β | 2018 | β |
| Microglial signatures and their role in health and disease. | Butovsky O et al. | β | 2018 | β |
| Migration-based selections of antibodies that convert bone marrow into trafficking microglia-like cells that reduce brain amyloid Ξ². | Han KH et al. | β | 2018 | β |
| Modeling neurological diseases using iPSC-derived neural cells : iPSC modeling of neurological diseases. | Li L et al. | β | 2018 | β |
| Modeling Neurological Diseases With Human Brain Organoids. | Wang H | β | 2018 | β |
| Modeling Parkinson's Disease Using Patient-specific Induced Pluripotent Stem Cells. | Li H et al. | β | 2018 | β |
| Modelling glioma invasion using 3D bioprinting and scaffold-free 3D culture. | van Pel DM et al. | β | 2018 | β |
| Modelling microglial function with induced pluripotent stem cells: an update. | Pocock JM et al. | β | 2018 | β |
| Modelling Sporadic Alzheimer's Disease Using Induced Pluripotent Stem Cells. | Rowland HA et al. | β | 2018 | β |
| Open chromatin dynamics reveals stage-specific transcriptional networks in hiPSC-based neurodevelopmental model. | Zhang S et al. | β | 2018 | β |
| Representing Diversity in the Dish: Using Patient-Derived <i>in Vitro</i> Models to Recreate the Heterogeneity of Neurological Disease. | Ghaffari LT et al. | β | 2018 | β |
| Research Models and Tools for the Identification of Antivirals and Therapeutics against Zika Virus Infection. | Alves MP et al. | β | 2018 | β |
| Stem Cells, Genome Editing, and the Path to Translational Medicine. | Soldner F et al. | β | 2018 | β |
| Studying the Brain in a Dish: 3D Cell Culture Models of Human Brain Development and Disease. | Brown J et al. | β | 2018 | β |
| Studying tissue macrophages in vitro: are iPSC-derived cells the answer? | Lee CZW et al. | β | 2018 | β |
| Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson's Disease. | Sommer A et al. | β | 2018 | β |
| The G protein-coupled receptor GPR34 - The past 20β―years of a grownup. | SchΓΆneberg T et al. | β | 2018 | β |
| The Kaleidoscope of Microglial Phenotypes. | Dubbelaar ML et al. | β | 2018 | β |
| The Trem2 R47H Alzheimer's risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans. | Xiang X et al. | β | 2018 | β |
| Translational potential of human brain organoids. | Sun AX et al. | β | 2018 | β |
| 3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders. | Lee CT et al. | β | 2017 | β |
| A Highly Efficient Human Pluripotent Stem Cell Microglia Model Displays a Neuronal-Co-culture-Specific Expression Profile and Inflammatory Response. | Haenseler W et al. | β | 2017 | β |
| A human microglia-like cellular model for assessing the effects of neurodegenerative disease gene variants. | Ryan KJ et al. | β | 2017 | β |
| An Efficient Platform for Astrocyte Differentiation from Human Induced Pluripotent Stem Cells. | Tcw J et al. | β | 2017 | β |
| An environment-dependent transcriptional network specifies human microglia identity. | Gosselin D et al. | β | 2017 | β |
| An updated assessment of microglia depletion: current concepts and future directions. | Han J et al. | β | 2017 | β |
| Application of CRISPR/Cas9 to the study of brain development and neuropsychiatric disease. | Powell SK et al. | β | 2017 | β |
| Bioengineered 3D Glial Cell Culture Systems and Applications for Neurodegeneration and Neuroinflammation. | Watson PMD et al. | β | 2017 | β |
| Cellular and Molecular Characterization of Microglia: A Unique Immune Cell Population. | Sousa C et al. | β | 2017 | β |
| Differentiation of human and murine induced pluripotent stem cells to microglia-like cells. | Pandya H et al. | β | 2017 | β |
| Directed Differentiation of Human Pluripotent Stem Cells to Microglia. | Douvaras P et al. | β | 2017 | β |
| Drug discovery for remyelination and treatment of MS. | Cole KLH et al. | β | 2017 | β |
| Editorial: Minding Glial Cells in the Novel Understandings of Mental Illness. | Kato TA et al. | β | 2017 | β |
| Excess Ξ±-synuclein compromises phagocytosis in iPSC-derived macrophages. | Haenseler W et al. | β | 2017 | β |
| Fibromyalgia and microglial TNF-Ξ±: Translational research using human blood induced microglia-like cells. | Ohgidani M et al. | β | 2017 | β |
| Generating CNS organoids from human induced pluripotent stem cells for modeling neurological disorders. | Brawner AT et al. | β | 2017 | β |
| Human Induced Pluripotent Stem Cell-Derived Macrophages for Unraveling Human Macrophage Biology. | Zhang H et al. | β | 2017 | β |
| Induced-Pluripotent-Stem-Cell-Derived Primitive Macrophages Provide a Platform for Modeling Tissue-Resident Macrophage Differentiation and Function. | Takata K et al. | β | 2017 | β |
| In Vivo Imaging of Microglial Calcium Signaling in Brain Inflammation and Injury. | Tvrdik P et al. | β | 2017 | β |
| iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases. | Abud EM et al. | β | 2017 | β |
| Microglia and Monocytes/Macrophages Polarization Reveal Novel Therapeutic Mechanism against Stroke. | Kanazawa M et al. | β | 2017 | β |
| Microglia emerge as central players in brain disease. | Salter MW et al. | β | 2017 | β |
| Microglia in Physiology and Disease. | Wolf SA et al. | β | 2017 | β |
| Microglia-targeted stem cell therapies for Alzheimer disease: A preclinical data review. | Shen Z et al. | β | 2017 | β |
| Modeling neurodevelopmental and psychiatric diseases with human iPSCs. | Wen Z | β | 2017 | β |
| Modeling the C9ORF72 repeat expansion mutation using human induced pluripotent stem cells. | Selvaraj BT et al. | β | 2017 | β |
| Modulation of Hematopoietic Lineage Specification Impacts TREM2 Expression in Microglia-Like Cells Derived From Human Stem Cells. | Amos PJ et al. | β | 2017 | β |
| On place and time: microglia in embryonic and perinatal brain development. | Thion MS et al. | β | 2017 | β |
| Pluripotent stem cell-derived organoids: using principles of developmental biology to grow human tissues in a dish. | McCauley HA et al. | β | 2017 | β |
| Potassium channel expression and function in microglia: Plasticity and possible species variations. | Nguyen HM et al. | β | 2017 | β |
| Prospects for Modeling Abnormal Neuronal Function in Schizophrenia Using Human Induced Pluripotent Stem Cells. | Prytkova I et al. | β | 2017 | β |
| Should We Stop Saying 'Glia' and 'Neuroinflammation'? | Masgrau R et al. | β | 2017 | β |
| Stem cell models of Alzheimer's disease: progress and challenges. | Arber C et al. | β | 2017 | β |
| Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms. | Stonesifer C et al. | β | 2017 | β |
| The Importance of Non-neuronal Cell Types in hiPSC-Based Disease Modeling and Drug Screening. | Gonzalez DM et al. | β | 2017 | β |
| Transcriptomic analysis of purified human cortical microglia reveals age-associated changes. | Galatro TF et al. | β | 2017 | β |
| Advances in Zika Virus Research: Stem Cell Models, Challenges, and Opportunities. | Ming GL et al. | β | 2016 | β |
| Increasing the neurological-disease toolbox using iPSC-derived microglia. | Hammond TR et al. | β | 2016 | β |
| Leucine-Rich Repeat Kinase 2 Influences Fate Decision of Human Monocytes Differentiated from Induced Pluripotent Stem Cells. | Speidel A et al. | β | 2016 | β |
| Neuroimmunology: New approach allows derivation of microglia-like cells in vitro. | Fyfe I | β | 2016 | β |
| The promises and challenges of human brain organoids as models of neuropsychiatric disease. | Quadrato G et al. | β | 2016 | β |